Training event: Winter school

AMCARE/DRIVE Winter School takes place in Galway, Ireland

The DRIVE project in association with sister EU projects AMCARE and NEXT organised a Winter School training event: "Translational Reality of Advanced Therapy Medicinal Products (ATMPs)" in the Galway Bay Hotel from November 28th – December 1st 2016. All three projects are focused on the development of ATMPs (cell therapy products).

The training at the Winter School covered all the steps involved in the translation of ATMPs from the lab to the marketplace including: strategic engagement with industry, IP protection, GMP-compliant stem cell manufacture, preclinical validation of medical devices and clinical validation of cell therapy products, attracting venture capital and business planning and navigating the regulatory environment for ATMPs.

Invited speakers included experts from the AMCARE and DRIVE Consortium partners, collaborators from the National University of Ireland Galway (NUIG) and regulators from the Irish Health Products Regulatory Authority (HPRA). Attendees also visited the Centre for Cell Manufacturing Ireland (CCMI) at NUIG, Ireland's only GMP-compliant stem cell manufacturing facility, and Boston Scientific Ltd.'s ISO 14001-certified medical device research and manufacturing site in Ballybrit, Galway, the largest manufacturing facility in Boston Scientific's global network.

 

A photo gallery from the event:

Dr Nadège Grabowski,

Dr Nadège Grabowski,

Dr Nadège Grabowski, CelyadEU Program Manager delivering her expert lecture and case study on translating cell therapy products on day 3 of the AMCARE/DRIVE Winter School
Shannon Layland

Shannon Layland

Shannon Layland, Fraunhofer IGB Entrepreneur delivers his expert case study on the regenerative medicine spin-off Renovatum Therapeutics
AleardoFurlani

AleardoFurlani

AleardoFurlani, CEO ofInnova delivering his expert lecture and case study on attracting venture capital and business planning on day 3 of the AMCARE/DRIVE Winter School
Dr Steve Elliman

Dr Steve Elliman

Dr Steve Elliman, Orbsen Therapeutics CSO delivering his expert talk on day 2 of the AMCARE/DRIVE Winter School at NUIG

     This project has received funding from the EU Horizon 2020 research and innovation programme. Grant agreement No 645991